Wuhan Hiteck Biological Pharma Co Ltd (300683) — Capital Reinvestment Ratio
Wuhan Hiteck Biological Pharma Co Ltd (300683) has a Capital Reinvestment Ratio of 1.14x as of September 2024, meaning it reinvests 1% of its operating cash flow (CN¥4.86 Million) in capital expenditures (CN¥5.52 Million). See Wuhan Hiteck Biological Pharma Co Ltd (300683) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Wuhan Hiteck Biological Pharma Co Ltd Capital Reinvestment Ratio (2013–2024)
This chart tracks Wuhan Hiteck Biological Pharma Co Ltd's Capital Reinvestment Ratio across 11 annual periods.
Annual Capital Reinvestment Ratio for Wuhan Hiteck Biological Pharma Co Ltd (2013–2024)
Year-by-year Capital Reinvestment Ratio for Wuhan Hiteck Biological Pharma Co Ltd from 2013 to 2024. For live market cap and broader valuation context, see 300683 market cap.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.90x | CN¥22.69 Million | CN¥43.08 Million | ▼ -94.0% |
| 2023 | 31.51x | CN¥5.31 Million | CN¥167.44 Million | ▲ +860.5% |
| 2022 | 3.28x | CN¥53.03 Million | CN¥173.97 Million | ▼ -84.0% |
| 2021 | 20.44x | CN¥12.09 Million | CN¥247.11 Million | ▲ +1009.2% |
| 2019 | 1.84x | CN¥63.03 Million | CN¥116.15 Million | ▲ +249.9% |
| 2018 | 0.53x | CN¥73.42 Million | CN¥38.67 Million | ▲ +96.6% |
| 2017 | 0.27x | CN¥83.08 Million | CN¥22.25 Million | ▲ +74.8% |
| 2016 | 0.15x | CN¥143.86 Million | CN¥22.05 Million | ▲ +79.9% |
| 2015 | 0.09x | CN¥159.89 Million | CN¥13.62 Million | ▼ -26.3% |
| 2014 | 0.12x | CN¥135.40 Million | CN¥15.64 Million | ▼ -43.5% |
| 2013 | 0.20x | CN¥76.82 Million | CN¥15.71 Million | — |